Kronos Bio Correlations

KRON Stock

USD 0.95 0.01 1.04%

The current 90-days correlation between Kronos Bio and Achilles Therapeutics PLC is 0.13 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Kronos Bio Correlation With Market

Significant diversification

The correlation between Kronos Bio and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kronos Bio and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.

Moving together with Kronos Stock

0.65	HLN	Haleon plc	Pair Corr
0.69	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.68	LLY	Eli Lilly	Pair Corr
0.68	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.68	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	RDY	Dr Reddys Laboratories	Pair Corr
0.67	TAK	Takeda Pharmaceutical	Pair Corr
0.66	ABBV	AbbVie Inc Sell-off Trend	Pair Corr
0.63	AMGN	Amgen Inc	Pair Corr
0.62	ANEB	Anebulo Pharmaceuticals	Pair Corr
0.62	TEVA	Teva Pharma Industries	Pair Corr

Moving against Kronos Stock

0.69	VTRS	Viatris	Pair Corr
0.63	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.63	GILD	Gilead Sciences	Pair Corr
0.6	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.42	EWTX	Edgewise Therapeutics	Pair Corr
0.41	EBS	Emergent Biosolutions	Pair Corr
0.41	WAT	Waters	Pair Corr
0.4	BHC	Bausch Health Companies	Pair Corr
0.71	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.69	MNMD	Mind Medicine	Pair Corr
0.51	DXCM	DexCom Inc Sell-off Trend	Pair Corr
0.49	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.49	ABT	Abbott Laboratories Sell-off Trend	Pair Corr
0.35	CMND	Clearmind Medicine Common	Pair Corr

Related Correlations Analysis

	CYCN	LRMR	ADXN	ACHL	NXTC	CTMX	NLTX	SPRO	ASMB	REPL
CYCN		0.36	0.76	-0.56	0.49	0.59	0.3	0.65	0.41	-0.49	CYCN
LRMR	0.36		0.59	-0.19	0.42	0.08	-0.08	0.43	0.44	-0.07	LRMR
ADXN	0.76	0.59		-0.42	0.48	0.5	0.02	0.57	0.39	-0.31	ADXN
ACHL	-0.56	-0.19	-0.42		-0.54	-0.67	-0.45	-0.64	-0.31	0.61	ACHL
NXTC	0.49	0.42	0.48	-0.54		0.46	0.41	0.66	0.27	-0.66	NXTC
CTMX	0.59	0.08	0.5	-0.67	0.46		0.4	0.64	0.28	-0.5	CTMX
NLTX	0.3	-0.08	0.02	-0.45	0.41	0.4		0.57	0.03	-0.71	NLTX
SPRO	0.65	0.43	0.57	-0.64	0.66	0.64	0.57		0.31	-0.52	SPRO
ASMB	0.41	0.44	0.39	-0.31	0.27	0.28	0.03	0.31		-0.21	ASMB
REPL	-0.49	-0.07	-0.31	0.61	-0.66	-0.5	-0.71	-0.52	-0.21		REPL
	CYCN	LRMR	ADXN	ACHL	NXTC	CTMX	NLTX	SPRO	ASMB	REPL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADXN	+ 0.76	CYCN
SPRO	+ 0.66	NXTC
SPRO	+ 0.65	CYCN
SPRO	+ 0.64	CTMX
REPL	+ 0.61	ACHL
CTMX	+ 0.59	CYCN

High negative correlations

REPL	- 0.71	NLTX
CTMX	- 0.67	ACHL
REPL	- 0.66	NXTC
SPRO	- 0.64	ACHL
ACHL	- 0.56	CYCN
NXTC	- 0.54	ACHL

Risk-Adjusted Indicators

There is a big difference between Kronos Stock performing well and Kronos Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kronos Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CYCN	7.00	0.59	0.03	(0.36)	9.14	(8.14)	18.75	(15.79)	77.82
LRMR	4.20	(0.45)	0.00	(0.11)	0.00	0.00	10.87	(9.55)	26.71
ADXN	3.70	(0.32)	0.00	(0.17)	0.00	0.00	9.74	(7.15)	29.35
ACHL	1.97	0.52	0.23	0.51	1.39	(3.11)	3.06	(2.78)	38.16
NXTC	2.58	(0.37)	0.00	1.82	0.00	0.00	5.22	(6.37)	21.68
CTMX	2.78	(0.24)	0.00	(0.06)	0.00	0.00	6.25	(5.22)	20.61
NLTX	2.25	(0.11)	0.00	0.34	0.00	0.00	4.05	(3.53)	27.84
SPRO	1.77	(0.32)	0.00	(0.57)	0.00	0.00	3.79	(4.58)	14.92
ASMB	2.92	0.06	0.00	0.32	4.39	(2.87)	8.79	(5.34)	21.34
REPL	3.32	0.38	0.12	0.34	3.34	(3.59)	8.25	(6.02)	46.30

Kronos Bio Corporate Management

Christopher Dinsmore	Strategic Advisor	Profile
Stephanie Yao	Exec Communications	Profile
Barbara JD	Strategic Advisor	Profile
Marni Kottle	Sr Relations	Profile
Rocio Hoyos	Senior Management	Profile
Joshua Kazam	CoFounder Director	Profile
Sandra Gardiner	Interim Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC